EGFR testing and erlotinib use in non-small cell lung cancer patients in Kentucky

This study determined the frequency and factors associated with EGFR testing rates and erlotinib treatment as well as associated survival outcomes in patients with non small cell lung cancer in Kentucky. Data from the Kentucky Cancer Registry (KCR) linked with health claims from Medicaid, Medicare a...

Descripción completa

Detalles Bibliográficos
Autores principales: Larson, Kara L., Huang, Bin, Chen, Quan, Tucker, Thomas, Schuh, Marissa, Arnold, Susanne M., Kolesar, Jill M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433873/
https://www.ncbi.nlm.nih.gov/pubmed/32810185
http://dx.doi.org/10.1371/journal.pone.0237790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433873/
https://www.ncbi.nlm.nih.gov/pubmed/32810185
http://dx.doi.org/10.1371/journal.pone.0237790

Ejemplares similares